# Kaneshima Hideto

> Kaneshima Hideto is a startup investor at CellSource. See 0 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [CellSource](https://shizune.co/investors/profile/cellsource)
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/hideto-kaneshima-md-ph-d-3945755/?originalSubdomain=jp

Kaneshima Hideto is a startup investor at CellSource. Born in 1952, he was born in Niigata Prefecture. Doctor, Doctor of Medicine. Graduated from Nagoya University School of Medicine in 1978. Completed the Department of Pathology and Immunology in 1983. He studied at Stanford University School of Medicine in the United States since 1986. Leading professor and bio-venture company Sysomix founded inSilicon Valley, SaiboBaiyo Ni Yoru ShokuryoSeisan He, including gene therapy, cell transplant therapy, etc. . We also succeeded in IPO and experienced international R&D such as a subsidiary of Novartis Corporation. After that, he became independent as a consultant in the field of biotechnology and promoted the bio-healthcare business in Japan while supporting many companies across Japan and the United States. In 2016, he became the director and CSO of CellSource Co., Ltd. SaiboBaiyo Ni Yoru ShokuryoSeisan He wants to contribute to the practice of new treatments using adipose tissue and its stem cells.

## About CellSource

VC Fund · Tokyo, Japan

CellSource provides adipose-derived stem cell processing services, blood-derived processing contract services, and support services for compliance with laws and regulations in areas such as regenerative medicine.

5 contacts available at CellSource.

| Name | Title | Profile |
| --- | --- | --- |
| Hideo Koyama | Auditor | https://shizune.co/investors/profile/hideo-koyama |
| Hirohiko Hanaki | Director, Chief Compliance Officer (CCO) & Head of Regenerative Medicine Business Division | https://shizune.co/investors/profile/hirohiko-hanaki |
| Kaneshima Hideto | Chief Technical Advisor & Doctor of Medicine | https://shizune.co/investors/profile/kaneshima-hideto |
| Kenta Fujita | Executive Officer | https://shizune.co/investors/profile/kenta-fujita |
| Masahiro Samejima | General Counsel and Patent Attorney | https://shizune.co/investors/profile/masahiro-samejima |

## FAQ

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co